中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
35期
17-18,19
,共3页
带状疱疹%阿昔洛韦%静脉注射
帶狀皰疹%阿昔洛韋%靜脈註射
대상포진%아석락위%정맥주사
Herpes zoster%Acyclovir%Intravenous injection
目的：分析静脉阿昔洛韦在带状疱疹治疗中的临床价值。方法：选取2011年2月-2013年12月在笔者所在医院治疗的129例带状疱疹患者，按照随机数字表法将其分为静脉阿昔洛韦组65例和口服阿昔洛韦组64例，观察比较两组患者的临床疗效、疼痛缓解时间、疱止时间、结痂时间、50%皮损结痂时间、皮损消退时间、VAS评分。结果：经治疗后，静脉阿昔洛韦组的治疗总有效率92.31%(60/65)明显高于口服阿昔洛韦组的73.44%(47/64)，疼痛缓解时间、疱止时间、结痂时间、50%皮损结痂时间、皮损消退时间均明显短于口服阿昔洛韦组，VAS评分明显低于口服阿昔洛韦组，差异均有统计学意义(P<0.05)。结论：静脉注射阿昔洛韦能够有效地治疗带状疱疹，控制带状疱疹神经痛，值得临床推广应用。
目的：分析靜脈阿昔洛韋在帶狀皰疹治療中的臨床價值。方法：選取2011年2月-2013年12月在筆者所在醫院治療的129例帶狀皰疹患者，按照隨機數字錶法將其分為靜脈阿昔洛韋組65例和口服阿昔洛韋組64例，觀察比較兩組患者的臨床療效、疼痛緩解時間、皰止時間、結痂時間、50%皮損結痂時間、皮損消退時間、VAS評分。結果：經治療後，靜脈阿昔洛韋組的治療總有效率92.31%(60/65)明顯高于口服阿昔洛韋組的73.44%(47/64)，疼痛緩解時間、皰止時間、結痂時間、50%皮損結痂時間、皮損消退時間均明顯短于口服阿昔洛韋組，VAS評分明顯低于口服阿昔洛韋組，差異均有統計學意義(P<0.05)。結論：靜脈註射阿昔洛韋能夠有效地治療帶狀皰疹，控製帶狀皰疹神經痛，值得臨床推廣應用。
목적：분석정맥아석락위재대상포진치료중적림상개치。방법：선취2011년2월-2013년12월재필자소재의원치료적129례대상포진환자，안조수궤수자표법장기분위정맥아석락위조65례화구복아석락위조64례，관찰비교량조환자적림상료효、동통완해시간、포지시간、결가시간、50%피손결가시간、피손소퇴시간、VAS평분。결과：경치료후，정맥아석락위조적치료총유효솔92.31%(60/65)명현고우구복아석락위조적73.44%(47/64)，동통완해시간、포지시간、결가시간、50%피손결가시간、피손소퇴시간균명현단우구복아석락위조，VAS평분명현저우구복아석락위조，차이균유통계학의의(P<0.05)。결론：정맥주사아석락위능구유효지치료대상포진，공제대상포진신경통，치득림상추엄응용。
Objective:To analyze the clinical value of intravenous Acyclovir in the treatment of herpes zoster.Method:129 patients with herpes zoster admitted to our hospital from February 2011 to December 2013 were selected,they were divided into the intravenous Acyclovir group for 65 cases and the oral Acyclovir group for 64 cases.The clinical effect,pain relief time,blister stop time,scabby time,50%lesions scabby time,skin fade time and VAS score between the two groups were observed and compared.Result:The total effective rate of intravenous Acyclovir group was 92.31%(60/65),it was significantly higher than 73.44%(47/64) of oral Acyclovir group,the pain relief time,blister stop time,scabby time,50%lesions scabby time,skin fade time in intravenous Acyclovir group were significantly shorter than those of oral Acyclovir group,the VAS score of intravenous Acyclovir group was significantly lower than oral Acyclovir group,the differences were statistically significant(P<0.05).Conclusion:Intravenous Acyclovir can effectively treat herpes zoster and control herpes zoster neuralgia,is worthy of clinical application.
